Envveno Medical (NVNO)Director sold ~$4.1K

~$4.1K

Approx. value · 4,900 sh @ $0.83

97K

Holds after · shares reported

Traded

Sep 15, 2025

Filed

Sep 17, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 15, 2025 · this disclosureInsiderDirector sold ~$4.1K of NVNO shares in the open market

What came next

1. Oct 7, 2025Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On October 7, 2025, enVVeno Medical Corporation (the “Company”) received notification from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market under Rule…”
2. Oct 30, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
3. Nov 17, 2025Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Envveno Medical

OQRO holds no insider, Congress, fund or contract record for Envveno Medical dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NVNO page.

Other recent filings by Francis Duhay, Director

• SEC Form 4 at Envveno Medical (NVNO)Jan 3, 2025

The full history of Francis Duhay, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Envveno Medical

• SEC Form 4Jan 3, 2025
• SEC Form 4Jan 2, 2025
• SEC Form 4Dec 26, 2024
• SEC Form 4Dec 23, 2024
• SEC Form 4Dec 20, 2024

Everything OQRO holds on this company is on its NVNO page.